Pharsight

Drugs that contain Bosentan

1. Tracleer patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8309126 ACTELION Dispersible bosentan tablet
May, 2026

(2 years from now)

US7959945 ACTELION Dispersible bosentan tablet
Dec, 2027

(3 years from now)

Drug Exclusivity Drug Exclusivity Expiration
Orphan Drug Exclusivity (ODE) Sep 5, 2024

Market Authorisation Date: 05 September, 2017

Treatment: NA

Dosage: TABLET, FOR SUSPENSION;ORAL

How can I launch a generic of TRACLEER before it's drug patent expiration?
More Information on Dosage

TRACLEER family patents

Family Patents